Cover Image

Splenic nodules as guiding signs in pediatric population with visceral leishmaniasis

Saved in:

Bibliographic Details
Main Authors:	María Marina Casero-González (Author), Lucía Izquierdo-Palomares (Author), Octavio Cañuelo-Ruiz (Author), Raúl Montero-Yéboles (Author), María José de la Torre-Aguilar (Author), Beatriz Ruiz-Sáez (Author)
Format:	Book
Published:	Elsevier, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nódulos esplénicos como signo guía de leishmaniasis visceral en población infantil
by: María Marina Casero-González, et al.
Published: (2022)

Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
by: Yaneth Osorio, et al.
Published: (2011)

SPLENIC INJURY-ANALYSIS OF CLINICAL SIGNS AND OUTCOMES
by: Konstantin Kostov
Published: (2020)

African American Woman with Liver Enlargement and Splenic Nodules - An Interactive Case Exercise
by: John Woosley
Published: (2010)

Visceral Leishmaniasis (Kala-Azar) and Pregnancy
by: Ernesto Antonio Figueiró-Filho, et al.
Published: (2004)

Epidemiology of visceral leishmaniasis in Georgia.
by: Giorgi Babuadze, et al.
Published: (2014)

Glomerulopathy Associated with Visceral leishmaniasis
by: Sh Khademvatan, et al.
Published: (2007)

Glomerulopathy Associated with Visceral leishmaniasis
by: Sh Khademvatan, et al.
Published: (2007)

Clinical Case. Visceral Leishmaniasis
by: I.V. Bogadelnikov, et al.
Published: (2014)

Dermatoscopic signs in cutaneous leishmaniasis
by: María Librada Porriño Bustamante, et al.
Published: (2017)

Visceral Leishmaniasis in Kerala: An Emerging Disease
by: Priya Chandran, et al.
Published: (2016)

Innovations for the elimination and control of visceral leishmaniasis.
by: Angamuthu Selvapandiyan, et al.
Published: (2019)

Evidence for visceral leishmaniasis elimination in Nepal
by: Megha Raj Banjara, et al.
Published: (2020)

Visceral leishmaniasis in Ethiopia: an evolving disease.
by: Samson Leta, et al.
Published: (2014)

Research priorities for elimination of visceral leishmaniasis
by: Greg Matlashewski, et al.
Published: (2014)

Education is key to controlling visceral leishmaniasis
Published: (2010)

SPECIALIZED NURSING TERMINOLOGY FOR PEOPLE WITH VISCERAL LEISHMANIASIS
by: Diego Dias de Araújo, et al.
Published: (2023)

Visceral leishmaniasis and HIV coinfection in Latin America.
by: José Angelo Lindoso, et al.
Published: (2014)

Visceral leishmaniasis in large Brazilian cities: challenges for control
by: Claudia Di Lorenzo Oliveira, et al.
Published: (2008)

Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.
by: Dinesh Mondal, et al.
Published: (2019)

Control of Visceral Leishmaniasis by Immunotherapeutic and Prophylactic Strategies
by: Alexandre Barbosa Reis
Published: (2015)

Maiden Visit of Visceral Leishmaniasis to Malwa Region
by: Shirish S Nandedkar, et al.
Published: (2013)

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014)

Underestimated CNS involvement during Visceral Leishmaniasis
by: M. Grigoryan, et al.
Published: (2020)

Visceral leishmaniasis and HIV coinfection in the Mediterranean region.
by: Begoña Monge-Maillo, et al.
Published: (2014)

Risk factors for death in children with visceral leishmaniasis.
by: Márcia Jaqueline Alves de Queiroz Sampaio, et al.
Published: (2010)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis.
by: Rebecca J Faleiro, et al.
Published: (2016)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
by: Ayako Morimoto, et al.
Published: (2016)

Visceral leishmaniasis research: operational focus needed
by: Richard Reithinger
Published: (2015)

Visceral leishmaniasis as a possible reason for pancytopenia
by: Kira-Lee eKoster, et al.
Published: (2015)

Immune regulation during chronic visceral leishmaniasis.
by: Rebecca J Faleiro, et al.
Published: (2014)

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
by: Adriana Bezerra-Souza, et al.
Published: (2019)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014)

Clinical and epidemiological aspects of visceral leishmaniasis in children
by: Lívia Moreira Barros, et al.
Published: (2014)

Pharmacotherapeutic Options for Visceral Leishmaniasis-Current Scenario
by: Krishna Pandey MD, et al.
Published: (2009)

Leishmaniasis visceral: senderos que confluyen, se bifurcan
by: Oscar Daniel Salomón, et al.
Published: (2012)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013)

Expansão geográfica da leishmaniose visceral no Brasil Geographic spread of visceral leishmaniasis in Brazil
by: Guilherme L. Werneck
Published: (2010)